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Extracellular ATP is known to inhibit growth of various tumours by activating speciﬁc purinergic receptors (P2-receptors).
Since the therapy of advanced oesophageal cancer is unsatisfying, new therapeutic approaches are mandatory. Here, we
investigated the functional expression and potential antiproliferative effects of P2-purinergic receptors in human oesophageal
cancer cells. Prolonged incubation of primary cell cultures of human oesophageal cancers as well as of the squamous
oesophageal cancer cell line Kyse-140 with ATP or its stable analogue ATPgS dose-dependently inhibited cell proliferation.
This was due to both an induction of apoptosis and cell cycle arrest. The expression of P2-receptors was examined by RT-
PCR, immunocytochemistry, and [Ca
2+]i-imaging. Application of various extracellular nucleotides dose-dependently increased
[Ca
2+]i. The rank order of potency was ATP=UTP4ATPgS4ADP=UDP. 2-methylthio-ATP and a,b-methylene-ATP had no
effects on [Ca
2+]i. Complete cross-desensitization between ATP and UTP was observed. Moreover, the phospholipase C
inhibitor U73122 dose-dependently reduced the ATP triggered [Ca
2+]i signal. The pharmacological features strongly suggest
the functional expression of G-protein coupled P2Y2-receptors in oesophageal squamous cancer cells. P2Y2-receptors are
involved in the antiproliferative actions of extracellular nucleotides. Thus, P2Y2-receptors are promising target proteins for
innovative approaches in oesophageal cancer therapy.
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ATP and related compounds are widespread transmitters for extra-
cellular communication in many cell types. By coupling to speciﬁc
purinergic receptors ATP is involved in a large variety of cellular
functions (Ralevic and Burnstock, 1998). The classiﬁcation of P2
purinergic receptors, ﬁrst suggested by Burnstock in the late seven-
ties (Burnstock, 1978) distinguished between two major classes of
P2-purinoceptors, ﬁrst ionotropic P2-receptors (P2X), which are
ligand-gated receptors containing an intrinsic ion channel, and
second metabotropic P2-receptors (P2Y), which belong to the
superfamily of G-protein coupled receptors. This classiﬁcation
has recently been expanded (Barnard et al, 1994; Fredholm et al,
1997) to accommodate the results of cloning studies which revealed
the existence of multiple subclasses of P2Y purinoceptors. While
ionotropic P2X-receptors are mainly expressed in the nervous
system, platelets and in smooth muscle cells, metabotropic P2Y-
receptors are distributed in a large variety of tissues, including
epithelial tissues of the gastrointestinal system (Dubyak and el-
Moatassim, 1993; Roman and Fitz, 1999). P2Y-receptors mainly
couple to Gq/11-proteins to activate phospholipase C. Upon activa-
tion phosphatidylinositolbisphosphate (PIP2) is hydrolyzed leading
to the generation of IP3 (inositoltrisphosphate), which triggers
calcium release from intracellular stores (SR/ER) (Lytton et al,
1991). Depletion of intracellular calcium stores in turn induces
calcium inﬂux across the plasma membrane (Lytton et al, 1991).
This Ca
2+-inﬂux mechanism, which depends on an initial elevation
of [Ca
2+]i, has been referred to as ‘calcium release’ activated
calcium inﬂux’ or ‘capacitative calcium entry’ (Berridge, 1995).
ATP is known to inhibit cancer growth in various tumour
models (Rapaport, 1990; Haskell et al, 1996; Correale et al, 1997;
Ishikawa et al, 1997). ATP-induced apoptosis was in the past
considered to be mediated by ionotropic P2-receptors only (Fred-
holm et al, 1994; Bronte et al, 1996; Correale et al, 1997). However,
there is growing evidence that by altering intracellular calcium
concentrations metabotropic P2-receptors may be involved in both
growth inhibition and programmed cell death (Fang et al, 1992;
Duncan et al, 1996; McConkey and Orrenius, 1997; Ho ¨pfner et
al, 2001).
Oesophageal cancers have not been studied in this respect so far.
Therefore we investigated the P2-receptor-mediated, cell cycle
arresting and apoptosis inducing effects of extracellular nucleotides
in oesophageal cancer cells.
MATERIALS AND METHODS
Materials
Fura-2/AM, gramicidin, ATP, ATPgS, UTP, ADP, UDP, 2-
methylthio-ATP (2MeSATP), a,b-methylene-ATP (a,b-meATP)
and adenosine were purchased from Sigma Chemicals Co. (Mu ¨nch-
en, Germany). SBFI/AM and pluronic-F127 were purchased from
Molecular Probes (Eugene OR, USA). RPMI 1640 was obtained
from Biochrom-Seromed KG (Berlin, Germany). All stock solu-
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www.bjcancer.comtions except from fura-2/AM, SBFI/AM and adenosine (solubilized
in DMSO) were prepared in water and stored in aliquots of appro-
priate size at 7208C until use.
Cell culture
The human oesophageal squamous carcinoma cell line Kyse-140
(Shimada et al, 1992) was maintained in standard RPMI 1640
medium, complemented with 10% foetal calf serum and was kept
in an incubator (378C, 5% CO2 humidiﬁed atmosphere).
Primary cell cultures of histologically veriﬁed oesophageal squa-
mous cell carcinomas were established from endoscopic biopsies of
seven oesophageal cancer patients (three female, four male patients,
age: 52–69 years). The human tumour material was used accord-
ing to the standards set by the Ethical Committee of the Benjamin
Franklin University Hospital, Free University of Berlin, Germany.
Preparation was performed by mechanical dissection using an
automated disaggregation system (Medimachine; Becton Dickin-
son, Heidelberg, Germany) as described elsewhere in detail
(Maaser et al, 2001). The isolated human oesophageal carcinoma
cells were maintained in nutrient medium based on Earle’s 199-
medium (Biochrom, Berlin, Germany) complemented with 20%
foetal calf serum, 2 mML -glutamine, 2% (v/v) Biotect protective-
medium (Biochrom, Berlin, Germany), penicillin (100 U ml
71),
streptomycin (100 mgm l
71), amphotericin B (1% v/v) and were
kept in an incubator (378C, 5% CO2 humidiﬁed atmosphere). Half
of the medium was changed every second day. Cells remained in
culture for at least 2 days before the experiments were carried
out. Squamous epithelial origin of the isolated primary culture cells
was conﬁrmed by immunostaining with a FITC-labelled cytokera-
tin antibody (cytokeratin/FITC clone MNF 116, DAKO,
Hamburg, Germany).
Cell proliferation assay
Antiproliferative effects of a sustained application of P2-receptor
agonists on human oesophageal carcinoma cells were studied by
performing proliferation assays according to the crystal violet
method (Gillies et al, 1986). In brief, Kyse-140 cells were seeded
on 96-well plates at a density of 5000 cells per well. ATP, ATPgS,
2MeSATP or adenosine were added in concentrations from 100
to 500 mM. If stated, cells were additionally treated with 10 or
100 mM of the ecto-ATPase inhibitor ARL 67156 (6-N,N-
diethyl-b-g-dibromomethylene-D-adenosine-5'-triphosphate triso-
dium; RBI, Natick, MA, USA) which was given 1 h before as
well as during nucleotide incubation. Each concentration group
consisted of 10 wells. The incubation medium was changed daily.
Cells of each well were washed with phosphate-buffered saline
(PBS) and ﬁxed with 100 ml glutaraldehyde (1% v/v) in PBS for
15 min at room temperature. After another washing step cells were
stained with 0.1% crystal violet in PBS for 30 min at room
temperature. The unbound dye was removed by washing with
H2O for 30 min. Crystal violet which had absorbed onto the cells
was solubilized with 100 ml Triton X-100 (0.2%) in PBS for at least
24 h at 378C. The crystal violet coloured solution was spectro-
photometrically measured at 570 nm using an ELISA-Reader. In
the range between 500 to 100000 cells per well the measured
extinction was linear to the number of cells.
Cell cycle analysis
Cell cycle analysis was performed by using the method of Vindelov
and Christensen (1990). 5610
5 cells per well were cultured for
24 h and then exposed to the respective nucleotide for another
24 h. Cells were trypsinized, washed, and the nuclei were isolated
using CycleTest PLUS DNA Reagent Kit (Becton Dickinson,
Heidelberg, Germany). DNA was stained with propidium iodide
according to the manufacturers’ instructions. The DNA content
of the nuclei was detected by ﬂow cytometry and analyzed using
CellFit software (Becton Dickinson, Heidelberg, Germany).
Caspase-3 activity assay
Cells were incubated with medium containing ATP or ATPgSa t
concentrations from 50 to 500 mM for 48 h, washed twice with
PBS, and stored at 7808C until use. Approximately 10
6 cells were
lysed with 500 ml lysis buffer (10 mM Tris-HCl, 10 mM NaH2PO4/
Na2HPO4, 130 mM NaCl, 1% Triton X-100, 10 mM NaPPi, pH 7.5)
and total protein content was quantiﬁed using the BCA protein
assay kit (Pierce, Rockford, IL, USA). Caspase-3 activity was calcu-
lated from the cleavage of the ﬂuorogenic substrate DEVD-AMC
(Nicholson et al, 1995). In brief, 100 ml cell lysate containing
500 mgm l
71 protein was incubated with 100 ml substrate solution
(2 mg caspase-3 substrate AC-DEVD-AMC, 20 mM HEPES, 10%
glycerol, 2 mM DTT, pH 7.5) for 1 h at 378C. Cleavage of
DEVD-AMC was measured with a VersaFluor ﬂuorometer (Biorad,
Munich, Germany) using a 360 nm excitation and a 460 nm emis-
sion wavelength.
TUNEL assay
Determination of apoptosis speciﬁc DNA strand breaks was
performed by terminal deoxynucleotidyl transferase-mediated
dUTP nick-end labelling (TUNEL) assay (Li et al, 1996) according
to the manufacturers’ instructions (Roche, Mannheim, Germany).
Cells were ﬁxed with 4% paraformaldehyde for 1 h at room
temperature, washed once with 200 ml 1% BSA in PBS, followed
by permeabilization with 0.1% Triton X-100 in 0.1% sodium
citrate solution for 2 min on ice. After washing with 200 ml1 %
BSA in PBS, cells were stained with 50 ml TUNEL reaction mixture
(Roche, Mannheim, Germany) for 1 h at 378C in a humidiﬁed
atmosphere in the dark. After two additional washing steps, nuclear
ﬂuorescence was analyzed using a Zeiss Axioskop-2 microscope.
Reverse transcriptase chain reaction (RT–PCR)
RNA isolation, reverse transcription and PCR reactions were
carried out as described elsewhere in detail (Glassmeier et al,
1998). Total RNA was isolated from cells using the RNeasy Kit
(Qiagen, Valencia, CA, USA) according to the manufacturers’
instructions. To eliminate any possible contamination with geno-
mic DNA, RNAs were treated with 1 U DNAse I (Gibco,
Karlsruhe, Germany) per mg RNA for 15 min at room tempera-
ture. Furthermore, possible contamination with genomic DNA
was excluded by control experiments omitting the reverse tran-
scriptase. Puriﬁed RNA was reverse transcribed into cDNA
using the oligo-dT-primers and the SuperScript Preampliﬁca-
tion-Kit (Gibco, Karlsruhe, Germany). PCR reactions were
carried out in a total volume of 50 ml containing 400 nM of each
primer, 200 mM of each dNTP (Pharmacia, Uppsala, Sweden),
50 mM KCl, 1.5 mM MgCl2,1 0m M Tris, and 1 Unit Taq-poly-
merase (Pharmacia, Uppsala, Sweden). PCR was performed in a
Peltier-thermocycler (PTC-200, MJ-Research, USA) at the follow-
ing conditions: Initial heating to 958C for 5 min, then 30 cycles at
958C for 30 s, 608C for 30 s for P2X- and P2Y6-primers, or 708C
for 30 s for P2Y1,2,4-primers, or 638C for 1 min for b-actin
primers, respectively, and 728C for 1 min, followed by a ﬁnal
elongation step of 7 min at 728C. Ampliﬁcation of the cDNA
sequences encoding for the tested human P2-receptor subtypes
was performed using speciﬁc and established primer sequences
(Scho ¨ﬂ et al, 1999; Yamamoto et al, 2000; Ho ¨pfner et al, 2001)
as shown in Table 1. The speciﬁcity of the cDNA products was
additionally controlled by direct sequencing which was performed
by Invitek Sequencing Service GmbH, Berlin-Buch, Germany. As a
control for the amount of cDNA, RT–PCR was performed using
b-actin primers (Table 1).
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(4), 636–644Immunoﬂuorescence labelling and ﬂuorescence
microscopy
Cells were washed with PBS, ﬁxed by incubation with 4% parafor-
maldehyde in PBS for 30 min at room temperature, and washed
again with PBS. Cells were then incubated for 3 h at room
temperature with 5 mgm l
71 polyclonal rabbit-anti-human P2Y2
antibody, which was kindly provided by Dr BK Kishore (Kishore
et al, 2000), or with 5 mgm l
71 polyclonal rabbit-anti-human
P2Y4 antibody Ab-1 (Oncogene, Cambridge, CA, USA). Thereafter
cells were washed twice with PBS and incubated with 4 mgm l
71
secondary Alexa
TM 488-labelled goat-anti-rabbit IgG antibody
(Molecular Probes, Eugene, OR, USA) for 1 h at room tempera-
ture. Fluorescence and transmission images were obtained using
a Zeiss Axioskop-2 microscope.
Measurement of intracellular calcium and sodium
Kyse-140 cells were grown on 25 mm glass coverslips coated with
poly-L-lysine for improved attachment. For measurement of intra-
cellular calcium cells were loaded with the ﬂuorescent dye fura-2/
AM (5 mM) for 45 min at room temperature in a bath solution
containing: 130 mM NaCl, 5.4 mM KCl, 1 mM CaCl2,1m M MgCl2,
10 mM glucose and 10 mM HEPES, adjusted to pH 7.3 with
NaOH. The constituents of Ca
2+-free solutions were the same as
the bathing solution described above except that CaCl2 was omitted
and 0.1 mM EGTA was added to eliminate possible Ca
2+-contam-
inations of the other constituents. Fluorescence measurements
were performed at room temperature with a digital imaging system
of T.I.L.L. Photonics (Mu ¨nchen, Germany) (Glassmeier et al, 1998;
Ho ¨pfner et al, 1998). Fura-2 ﬂuorescence was excited alternatively
at 340 and 380 nm with a monochromator provided by a 75 W
xenon lamp. Cellular ﬂuorescence was ﬁltered through a 510 nm
band pass ﬁlter. Images were digitalized and analyzed by FUCAL
5.12c software of T.I.L.L. Photonics. Ratio images were generated
either at 1.5 or 2 s intervals. To compensate for background noise
illumination of a cell-free area was subtracted. The calculation of
the fura-2 signal was done as described in detail elsewhere (Morgan
and Thomas, 1999). To calculate [Ca
2+]i the equation of Grynkie-
wicz et al (1985) was used. The data are mainly represented as
changes in 340/380 nm (DF340/F380 nm) ﬂuorescence ratio, which
is proportional to [Ca
2+]i. Unless representative single tracings are
shown, the results are given as means+s.e.m.
Changes in intracellular sodium concentration were monitored
by loading the cells with the ﬂuorescent dye SBFI/AM (10 mM)
for 2 h at 378C, 5% CO2 humidiﬁed atmosphere in the same bath
solution as described above. For better dispersion of the dye in the
loading medium the nonionic and nondenaturing detergent pluro-
nic F-127 (0.04% (w/v)) was added. To remove extracellular
remainders of SBFI/AM, the cells were washed three times in bath
solution. Then the samples were kept in bath solution for at least
20 min to ensure complete intracellular de-esteraﬁcation of the
dye. Fluorescence recordings with SBFI-loaded cells were
performed under the same conditions as described above for
fura-2, except from the excitation wavelength of the Na
+-bound
dye which was 344 nm. The data are represented as changes in
344/380 nm (DF344/F380 nm) ﬂuorescence ratio, which is propor-
tional to [Na
+]i.
Statistical analysis
Comparison of multiple means was performed with nonparametric
ANOVA. Comparison of individual drug treatments to control
treatments was performed using an unpaired, two-tailed Mann–
Whitney U-test for proliferation and caspase-3 activity experi-
ments. Data are expressed as mean percentage of control+s.e.m.
For cell cycle analysis the unpaired student t-test was used. P values
were considered to be signiﬁcant at 50.05.
RESULTS
Growth inhibitory effects of extracellular nucleotides on
oesophageal cancer cells
ATP is known to inhibit cancer growth in various tumour models
(Agteresch et al, 1999). However, its role in growth control of
human oesophageal cancer remains elusive. To investigate putative
growth modulating effects of extracellular nucleotides in oesopha-
geal carcinoma cells, cell proliferation assays were performed with
Kyse-140 cells. For these experiments ATP, the hydrolysis resistant
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Table 1 Primers used to identify human P2-receptor subtypes
P2-receptor PCR-product
subtype Sequences of primer pairs size (bp)
P2X1 forward: 5'-AGTCTTCCAGCTTGGCTACG-3' 509
reverse: 5'-TCCTCATGTTCTCCTGCAGG-3'
P2X3 forward: 5'-TGCATATCCGACTTCTTCACC-3' 501
reverse: 5'-CTCAGCTTCCATCATGATGG-3'
P2X4 forward: 5'-AACTGCTCATCCTGGCCTAC-3' 412
reverse: 5'-ACGTGTGTGTCATCCTCCAC-3'
P2X5 forward: 5'-CAATGTGATGGACGTCAAGG-3' 517
reverse: 5'-TGTGAGCTGCTCAGATAGCC-3'
P2X7 forward: 5'-AAGGAATTCAGACCGGAAGG-3' 585
reverse: 5'-TTGAGCCGATGTACACAACC-3'
P2Y1 forward: 5'-TGTGGTGTACCCCCTCAAGTCCC-3' 260
reverse: 5'-ATCCGTAACAGCCCAGAATCAGCA-3'
P2Y2 forward: 5'-CCAGGCCCCCGTGCTCTACTTTG-3' 367
reverse: 5'-CATGTTGATGGCGTTGAGGGTGTG-3'
P2Y4 forward: 5'-CGTCTTCTCGCCTCCGCTCTCT-3' 432
reverse: 5'-GCCCTGCACTCATCCCCTTTTCT-3'
P2Y6 forward: 5'-CCGCTGAACATCTGTGTC-3' 464
reverse: 5'-AGAGCCATGCCATAGGGC-3'
b-actin forward: 5'-TTCCTGGGCATGGAGTCCTGTGG-3' 336
reverse: 5'-CGCCTAGAAGCATTTGCGGTGG-3'
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1A). Both ATP and ATPgS dose-dependently decreased cellular
proliferation. The poorly hydrolysable ATPgS was even more effec-
tive (IC50=234+51 mM after 72 h of incubation) than ATP
(IC50=450+31 mM). In contrast, 2MeSATP failed to inhibit the
growth of Kyse-140 cells even at a concentration of 500 mM.
Adenosine, the major breakdown product of ATP, showed no
effects on cellular proliferation up to 250 mM. Only at the high
adenosine concentration of 500 mM, mimicking the unlikely
complete degradation of the maximal ATP-dose of 500 mM to
adenosine, a growth inhibitory effect by adenosine of 24+6%
was observed, presumably mediated by an activation of adenosine
speciﬁc P1-receptors, which are ubiquitously expressed (Fang et
al, 1992; Vandewalle et al, 1994). However, the adenosine-evoked
effect is about 50% less than those of ATP at the same concentra-
tion of ATP (52+6%). This means that even in case of a complete
hydrolysis of ATP to adenosine, the antiproliferative effects of an
ATP treatment can only be partially explained by an involvement
of adenosine-mediated effects.
Ecto-ATPases are membrane bound enzymes which depho-
sphorylate ATP, thereby terminating the stimulatory effects of
ATP on P2-receptors. It has been shown by others that in several
tissues the activation of ecto-ATPases themself is capable of altering
intracellular second-messengers (e.g. NO) thereby also affecting cell
growth (Sneddon et al, 2000). To exclude a possible contribution
of ecto-ATPases in the regulation of cell growth, the effects of
the ecto-ATPase inhibitor ARL 67156 (10–100 mM) were investi-
gated. However, even 100 mM of the ecto-ATPase inhibitor ARL
67156 showed no signiﬁcant inﬂuence on proliferation of Kyse-
140 cells, thus excluding a contribution of ecto-ATPase signalling
to the observed growth inhibitory effects (data not shown).
Effects of extracellular nucleotides on the cell cycle
To investigate if the observed growth inhibiting effects of extra-
cellular nucleotides on oesophageal cancer cells were caused by
cell cycle arrest, cell cycle analysis was performed. After
sustained incubation of Kyse-140 cells with either ATP or
ATPgS for 24 h a dose-dependent increase of the proportion
of cells in the S-phase of the cell cycle was observed, indicating
S-phase delay of the cells (Figure 1B). To exclude a possible
contribution of breakdown products of ATP, in particular of
adenosine, cell cycle analysis was performed with adenosine.
In accordance with the proliferation data, adenosine (50–
500 mM) did not alter the regulation of the cell cycle (data
not shown).
Apoptotic effects of extracellular nucleotides
To check whether the antiproliferative effects of ATP and ATPgS,
respectively, were caused not only by cell cycle arrest but also by
an induction of programmed cell death, the activation of
caspase-3, a key-enzyme in the process of apoptosis, was investi-
gated in Kyse-140 cells. After 48 h of incubation ATP dose-
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Figure 1 Antiproliferative and cell cycle effects of nucleotides. (A) Extracellular ATP (^) and ATPgS( &) signiﬁcantly decreased the cell number of Kyse-
140 cells after 3 days of incubation in a dose-dependent manner (P50.05 for 100–500 mM). In contrast, 2MeSATP (*) or adenosine (D) showed no or
minor effects. The respective antiproliferative effects are given as the percentage of cells of the untreated controls (=100%). Means+s.e.m. of four inde-
pendent experiments are shown. (B) After 24 h of incubation both ATP and ATPgS altered the proportion of cells in the G1/G0-phase (white columns), S-
phase (hatched columns), and G2/M-phase (black columns) of the cell cycle. Means+s.e.m. of six independent experiments are shown.
Growthinhibitionof oesophagealcancerby extracellularnucleotides
K Maaser et al
639
ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(4), 636–644dependently induced an increase of caspase-3 activity. With 500 mM
ATP the caspase-3 activity was more than doubled compared to the
untreated control (Figure 2A). ATP-induced caspase-3 activity was
not due to a generation of adenosine, since adenosine (50–
500 mM) failed to stimulate caspase-3 activity in Kyse-140 cells
(data not shown). ATPgS did not affect caspase-3 activity (Figure
2A). Three to 72 h of incubation with rising concentrations of
ATPgS (50–500 mM) did not evoke signiﬁcant effects on caspase-
3 activity. To investigate a possible contribution of ecto-ATPase-
dependent generation of extracellular Pi by degradation of ATP,
which has already been shown to be involved in ATP-induced
apoptosis (Zoeteweij et al, 1993), we pre-incubated the cells with
100 mM of the ecto-ATPase-inhibitor ARL 67156. Under these
conditions the ATP (500 mM for 48 h) evoked induction of
caspase-3 activity decreased by 18+3.5% while ARL 67156 alone
even increased caspase-3 activity by 28+16 %. The data suggest
that ecto-ATPase dependent generation of extracellular Pi is
involved in ATP-induced apoptosis of oesophageal cancer cells.
In primary oesophageal cancer cells induction of apoptosis by
ATP was investigated by end-labelling of DNA with ﬂuorescein-
dUTP (TUNEL assay). Fluorescence microscopy of primary cell
cultures of oesophageal cancers treated with 500 mM ATP for
48 h revealed an increase in apoptosis speciﬁc DNA strand breaks
of 32.7+13% above the untreated control which showed an aver-
age proportion of apoptotic cells of 9.6+1.4%. (Figure 2B).
Expression of P2-receptor mRNA and protein
To elucidate which P2-receptor subtype(s) may be responsible for
the growth inhibiting and apoptotic effects of extracellular nucleo-
tides, the mRNA expression of ionotropic P2-receptors (P2X1,
P2X3, P2X4, P2X5, and P2X7) and metabotropic P2-receptors
(P2Y1, P2Y2, P2Y4, and P2Y6) was investigated by RT–PCR.
Kyse-140 cells expressed mRNAs of P2X4-, P2X5-, and P2Y2-recep-
tors (Figure 3A). Interestingly, no mRNA-expression of P2X1-o r
P2X7-receptors, which are mainly implicated in the induction of
apoptosis (Chow et al, 1997; Di Virgilio et al, 1998; Ferrari et al,
1999) was observed. The mRNA of P2Y2- and P2X4 receptors
was also detected in biopsies of human squamous cancers of the
oesophagus, while transcripts of P2X1 and P2X7 receptors were also
missing in the mRNA of oesophageal cancer biopsies (Figure 4A).
The speciﬁcity of PCR was conﬁrmed by direct sequencing of tran-
scripts (data not shown).
However, using immunocytochemistry only a P2Y2-receptor-
speciﬁc ﬂuorescence was detected in the membrane of either
Kyse-140 and primary culture cells (Figure 3B,D), whereas neither
Kyse-140 cells nor primary cell culture preparations showed any
speciﬁc staining for P2X4 receptors (Figure 3C,E). Thus it is likely,
that despite the mRNA expression of P2X4 receptors no translation
into P2X4 protein occurs in the cells.
Expression of functional P2-receptors
To evaluate which P2-receptor subtypes mediate apoptosis and cell
cycle arrest in oesophageal cancer cells, subtype-speciﬁc expression
of functional P2-receptors was investigated by measuring changes
in [Ca
2+]i.I nC a
2+-containing bath solution, ATP (100 mM)
induced a rapid biphasic increase of [Ca
2+]i. An initial transient
[Ca
2+]i peak was followed by a sustained plateau-phase (Figure
4A). Regardless of the omission of Ca
2+ from the extracellular bath,
ATP still induced a rapid but now only transient increase of
[Ca
2+]i (Figure 4B). This observation suggests that the initial
[Ca
2+]i peak was caused by the release of Ca
2+ from intracellular
stores, whereas the plateau-phase occurring under [Ca
2+]e-contain-
ing conditions was due to transmembraneous Ca
2+-inﬂux. The
biphasic [Ca
2+]i response to stimulation with ATP is a typical
feature of metabotropic P2Y-receptors. Similar to ATP, UTP
induced a comparable increase of [Ca
2+]i (Figure 4D), indicating
the expression of purine and pyrimidine-sensitive receptors in
oesophageal cancer cells. Pre-treatment of the cells with 100 mM
of either ATP or UTP prevented a second rise in [Ca
2+]i in
response to a consecutive stimulation with the respective other
nucleotide (Figure 4C,D). This complete homologous cross-desen-
sitization between ATP and UTP indicates that both nucleotides
were competitively acting on a common binding site. Since only
one metabotropic P2Y-receptor equipotently activated by either
ATP or UTP, is known so far, these data strongly suggest the func-
tional expression of P2Y2-receptors in Kyse-140 cells.
For further pharmacological characterization, a possible contri-
bution of P2X-receptors to the observed changes in [Ca
2+]i was
investigated by using the P2X-receptor speciﬁc agonists 2-
methylthio-ATP (2MeSATP) and a,b-methylene-ATP (a,b-
meATP). P2Y1-, P2Y11-, P2YADP- and the ionotropic P2X1–6-
receptors have been shown to be sensitive for 2MeSATP
(Lambrecht, 2000). However, 100 mM 2MeSATP did not evoke
any increase of [Ca
2+]i in Kyse-140 cells (Figure 4E). Even at the
high concentration of 500 mM, 2MeSATP showed no [Ca
2+]i-indu-
cing effects (data not shown). However, it has been shown by
others (Weidema et al, 2001), that activation of P2X4-receptors
does not necessarily inﬂuence [Ca
2+]i but is implicated in altera-
tions of intracellular sodium concentrations ([Na
+]i). Therefore
additional [Na
+]i-measurements with 2MeSATP were performed.
Nevertheless, applying 100 mM 2MeSATP on Kyse-140 cells,
preloaded with the [Na
+]i-sensitive dye SBFI (10 mM), did not
evoke alterations in [Na
+]i (Figure 5). Comparable negative results
were obtained by applying ATP or UTP (100 mM) (data not
shown). As positive control the cells were treated with 10 mM
gramicidin at the end of each experiment. Gramicidin is known
to perforate the cell membrane to become sodium-permeable
(Diarra et al, 2001). Gramicidin treatment always led to an increase
of [Na
+]i (Figure 5). In line with the negative results of P2X4-
immunocytochemistry our data suggest, that despite the mRNA
expression of P2X4-receptors, neither protein nor functional P2X4
receptor expression occurred in Kyse-140 cells.
As expected by the negative results of RT–PCR for the mRNA-
expression of P2X1 and P2X7 receptors, no increase in [Ca
2+]i was
observed when the cells were challenged by the P2X-receptor
agonist a,b-meATP, which additionally excluded a contribution
of these receptor subtypes in the observed apoptotic and cell cycle
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Figure 2 Apoptotic effects of extracellular nucleotides. (A) ATP (white
columns) but not ATPgS (black columns) dose-dependently induced cas-
pase-3 activity in Kyse-140 cells after 48 h of incubation. Caspase-3 activity
was measured as the cleavage of the ﬂuorogenic substrate DEVD-AM.
Means+s.e.m. of four independent experiments are given as the percen-
tage of ﬂuorescence compared to untreated control. (B) Nucleic DNA
fragmentation of human oesophageal primary culture cells was determined
using TUNEL assay. Incubation with 500 mM ATP for 48 h induced a signif-
icant increase of the proportion of nucleic ﬂuorescence staining. The pro-
portions of positively stained cells are shown as means+s.e.m. of three
independent preparations.
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order of potency of the applied nucleotides to increase [Ca
2+]i was
ATP=UTP4ATPgS4ADP=UDP442MeSATP=a,b-meATP. This
graded efﬁciency of different nucleotides to increase [Ca
2+]i reﬂects
the pharmacological pattern of P2Y2-receptors, which thus seems
to be the only functionally expressed P2-receptor subtype in squa-
mous oesophageal cancer cells.
P2Y2-receptors couple to phospholipase C via Gq/11 proteins
(Burnstock, 1997). To determine the role of phospholipase C in
the signalling pathway of P2Y2-receptors in Kyse-140 cells, the
speciﬁc phospholipase C inhibitor U73122 was used. U73122
dose-dependently inhibited the increase of [Ca
2+]i upon ATP
stimulation at micromolar concentrations, whereas its inactive
analogue U73343 showed little if any effect (Figure 6). Fifty mM
U73122 completely suppressed the ATP induced [Ca
2+]i-rises,
conﬁrming that in Kyse-140 cells P2Y2-receptors couple to phos-
pholipase C and thereby effect [Ca
2+]i-rises.
DISCUSSION
ATP is released from malignant cells in response to chemo- or
radiotherapy. Extracellular ATP is known to inhibit growth of
Ehrlich ascites tumour cells, colon cancer, ovarian cancer, endo-
metrial cancer, breast cancer, and ﬁbroblast cell lines (Estrela et
al, 1995; Correale et al, 1997; Ho ¨pfner et al, 1998; Katzur et al,
1999; Li et al, 2000; Schultze-Mosgau et al, 2000). Here we
provide evidence that extracellular nucleotides induce apoptosis
and cause cell cycle arrest in human squamous cancer cells of
the oesophagus.
ATP and ATPgS induced a delay in the S-phase of the cell cycle.
The cell cycle arresting effects of extracellular nucleotides were
similar to the ones elicited by the cytostatic drugs 5-ﬂuorouracil
and cisplatin in oesophageal cancer cells (Yamane et al, 1999; Mast-
bergen et al, 2000). Moreover, for breast and ovarian cancer a
positive correlation between S-phase fraction and the response to
anticancer agents has recently been documented (Chevillard et al,
1996; Kolfschoten et al, 2000). Hence, recruitment of cancer cells
to the S-phase of the cell cycle by ATP might sensitise oesophageal
cancer cells to a reinforced response to established chemotherapeu-
tic drugs. Furthermore, cyclin-dependent kinase inhibitors such as
ﬂavopiridol, a promising new class of anticancer drugs, showed
enhanced cytotoxity at cells arrested in the S-phase (Shapiro and
Harper, 1999). Hence, in addition to the antiproliferative action
of ATP on its own, possible synergistic effects of ATP and antican-
cer drugs will be interesting to investigate. Accordingly, a
synergistic antiproliferative effect of 5-FU and extracellular ATP
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(4), 636–644has recently been described in colorectal carcinoma cells (Ho ¨pfner
et al, 2001).
Besides its cell cycle interfering effects, ATP was shown to
induce apoptosis in oesphageal cancer cells as assessed by TUNEL
assays and measuring increases of caspase-3 activity. Both primary
cell cultures and Kyse-140 cells were shown to undergo apoptosis
upon ATP treatment. The ability of ATP to induce apoptosis via
P2-receptors in a [Ca
2+]i-dependent manner has been formerly
demonstrated by others (Chow et al, 1997). On the other hand,
using the hydrolysis resistant ATP derivative ATPgS, Katzur et al
(1999) observed P2Y2-mediated antiproliferative but not apoptosis
inducing effects in endometrial carcinoma cells. In our study both
nucleotides, ATP and the ATPgS, evoked rises of [Ca
2+]i, but only
ATP induced apoptosis. This suggests that in addition to the P2Y2-
receptor triggered [Ca
2+]i-increase other signalling pathways may
mediate apoptosis of oesophageal cancer cells in response to
ATP. Interestingly, Zoeteweij et al (1993) showed that in hepato-
cytes [Ca
2+]i-induced apoptosis after prolonged exposure to ATP
was dependent on the generation of extracellular inorganic phos-
phate (Pi), which resulted from an ecto-ATPase mediated
hydolysis of the applied extracellular ATP. Hence, inorganic phos-
phate might be an additional signal necessary to induce apoptosis
in oesophageal cancer cells. Since ATP is hydrolyzed by ubiqui-
tously expressed ecto-ATPases and ectonucleotidases, this could
explain, why the hydrolysis resistant ATP derivative ATPgS, which
is additionally known to be an effective ecto-ATPase-inhibitor
(Chen and Lin, 1997), failed to induce apoptosis speciﬁc caspase-
3 activation in oesophageal cancer cells. This interpretation was
supported by our ﬁnding that the ecto-ATPase-inhibitor ARL
67156, which diminished the generation of Pi by inhibiting ATP-
degradation, resulted in a reduced activation of ATP induced
caspase-3 activity.
Antiproliferative as well as apoptosis inducing actions of extra-
cellular nucleotides are thought to result from (prolonged)
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liferative effects of metabotropic P2Y-receptors have been
documented in various tumour models (Fang et al, 1992; Vande-
walle et al, 1994; Ho ¨pfner et al, 1998; Katzur et al, 1999;
Schultze-Mosgau et al, 2000), apoptosis inducing effects of P2Y-
receptors have only been shown in MCF-7-breast cancer (Vande-
walle et al, 1994) and colorectal carcinoma cells (Ho ¨pfner et al,
2001) so far. Here we provide evidence that the cell cycle arresting
and apoptosis inducing actions of ATP involved the activation of
P2Y2-receptors in oesophageal cancer cells. Expression of P2Y2-
receptors in primary culture cells of oesophageal cancers as well
as in Kyse-140 cells was revealed by both RT–PCR and by
immunocytochemistry. Performing [Ca
2+]i-imaging Kyse-140 cells
were shown to be equally sensitive to both purine and pyrimidine
nucleotides demonstrating the functionality of the expressed P2Y2-
receptor protein. The functional expression of the P2Y2-receptor
subtype was strengthened by the complete cross-desensitization
between the two major agonists, ATP and UTP. Furthermore,
the increase of [Ca
2+]i was shown to be PLC-dependent, indicating
that the induction of [Ca
2+]i was mediated by Gq/11-coupled and
PLC-linked metabotropic P2Y2-receptors.
However, the main P2-receptor subtypes implicated in apoptosis
are ionotropic P2X-receptors of the subtypes P2X1 and P2X7
(Chvatchko et al, 1996; Di Virgilio et al, 1998; Ferrari et al,
1999). P2X-receptors are mainly found in excitable tissues such
as smooth muscles and nerves, although P2X4-receptors have also
been reported in endocrine tissues (Ralevic and Burnstock, 1998).
However, neither in primary cultures of oesophageal cancers nor
in the oesophageal cancer cell line Kyse-140 mRNA expression of
either P2X1- or P2X7-receptors could be detected. Only transcripts
of the ionotropic P2-receptor subtypes P2X4 and P2X5 were found.
So far neither P2X4 nor P2X5 has been implicated in the induction
of apoptosis. Moreover, the functional expression of P2X5-recep-
tors is most unlikely, since the human P2X5-receptors described
are unable to form functional channels (North and Surprenant,
2000). Nevertheless, to examine the possible expression and func-
tionality of P2X4-receptors in oesophageal cancer cells immuno-
cytochemistry, [Ca
2+]i- and [Na
+]i-measurements were performed.
Immunoﬂuorescence microscopy with the speciﬁc P2X4-receptor
antibody Ab-1 failed to yield a P2X4-receptor staining in either
primary cultured cells or in the squamous oesophageal cancer cell
line Kyse-140. Also the application of the P2X4-receptor-speciﬁc
agonist 2MeSATP failed to alter [Ca
2+]i. Since it has been reported
that in osteoclasts P2X4-receptors do not couple to [Ca
2+]i-signal-
ling but inﬂuence [Na
+]i (Weidema et al, 2001), we performed
[Na
+]i-measurements. However, 2MeSATP induced alterations of
[Na
+]i could not be detected. Thus, on the basis of our data we
exclude protein and functional expression of P2X4-receptors in
oesophageal cancer cells – despite positive RT–PCR-ﬁndings.
Altogether, P2X-receptors do not appear to contribute to ATP-
induced [Ca
2+]i-signalling or to growth inhibition and apoptosis
in Kyse-140 oesophageal cancer cells.
To ensure that the observed antiproliferative effects of extracel-
lular nucleotides on oesophageal cancer cells were actually P2Y2-
receptor mediated events and were not caused by unspeciﬁc effects
of the applied nucleotides we also performed proliferation assays
with the P2X4-receptor agonist 2MeSATP. Since we have excluded
a functional expression of P2X4-receptors in the investigated oeso-
phageal cancer cells and it is known that 2MeSATP does not
activate P2Y2-receptors to a relevant extent (Ralevic and Burnstock,
1998), only unspeciﬁc signalling of the applied nucleotide could
yield antiproliferative effects. However, no contribution of
2MeSATP on the growth of oesophageal cancer cells could be
observed – even at a concentration of 500 mM. These data suggest
that the induction of growth inhibition and apoptosis in oesopha-
geal cancer cells by extracellular ATP and ATPgS was caused by the
activation of P2Y2-receptors, but was not due to unspeciﬁc effects
of these extracellular nucleotides.
To conclude, our data show that extracellular nucleotides cause
cell cycle arrest and induce apoptosis in human oesophageal carci-
noma cells. These actions are mediated by P2Y2-receptors.
Interestingly, ATP has already been studied as an anti-cachexia
and antiproliferative agent in advanced lung-cancer (Haskell et
al, 1996; Agteresch et al, 1999). Taken together, we therefore think
that P2Y2-receptors may qualify as promising targets for innovative
treatment strategies of oesophageal cancer.
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